Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study suggests protein may be early warning for ovarian cancer

12.08.2005


Penn State College of Medicine researchers have found a signal that could lead to earlier detection and treatment of ovarian cancer.



The Penn State team of scientists led by principal investigator Kathleen M. Mulder, Ph.D., professor of pharmacology, and working in conjunction with a researcher from the Center for Cancer Research, National Cancer Institute in Bethesda, Md., studied "km23," a protein that helps to direct protein traffic in the cell. Mulder’s team has found that at least 42 percent of ovarian cancer patient tumor tissues have alterations in km23. No similar alterations in km23 were detectable in normal human tissues, suggesting that it may be both a diagnostic indicator for the development of ovarian cancer and a possible target for cancer therapies. "While only close to half of ovarian cancer patients may have defects in km23, our results are still highly significant because there is no clinically useful screening test available for detection of ovarian cancer," said Mulder.

Additional studies are under way to continue the analyses of km23 abnormalities in specimens from women with ovarian cancer, and to determine whether different km23 alterations exist in other solid tumors, such as breast and colon cancer. "The next step is to develop a screening test for early detection of the km23 alterations in the blood of ovarian cancer patients," Mulder said. In addition, studies are under way to develop drugs that would target km23 and override the defects caused by the km23 alterations in the cancer cells. "The plan is to be able to use the screening test to identify those patients who would benefit from the anti-cancer drugs we will be developing using km23 as the target," Mulder said. "In the pharmaceutical industry, this is often referred to as ’personalized medicine,’ meaning that each patient can be checked for alterations in specific genes and their treatment targeted for the alterations specific to their cancer."


Epithelial ovarian cancer is often diagnosed at an advanced stage and accounts for more than 164,000 deaths annually. Despite advances in surgical techniques and chemotherapy, overall survival rates for women with ovarian cancer have not improved significantly because of late detection, often after the disease has already spread to remote organs. The identification of a potential early warning signal and a possible therapeutic target for the disease could lead to improved survival rates.

km23 is responsible, in part, for the movement of cellular proteins along microtubules, the "highways" of the cell. The cellular proteins, or "cargo," are actually driven along the microtubules by "motors" in the cell. km3 helps to connect the right cargo to the motor so that the cargo can reach its appropriate destination.

In a previous study, Mulder and her team found that the process is initiated by the binding of a factor called "TGFâ" to receptors on the cell’s surface. This, in turn, sends a signal to km23 telling it to attach to the motor and pick up the cargo. When km23 is altered, the cargo doesn’t reach the correct destination in the cell. As a result, a traffic jam occurs, which causes chaos in the cell.

This latest study, titled "A TGFâ receptor-interacting protein frequently mutated in human ovarian cancer," was published in the Aug. 1 issue of Cancer Research, http://cancerres.aacrjournals.org/.

The initiator of the journey, TGFâ, has been the focus of Mulder’s research program since 1988.

"TGFâ is a critical regulator of cell growth and is present throughout the body," she said. "It is already known to play an important role in suppressing the growth of epithelial cells, the type of cell that gives rise to solid tumors. When the appropriate signals are not sent by TGFâ, the growth of epithelial cells will not be controlled and a solid tumor can form. The alterations in km23 appear to disrupt some of the normal signals sent by TGFâ."

"The km23 alterations we have identified in human ovarian tumor tissues, described in our recent report, might also be used as prognostic indicators to help physicians decide on the most appropriate treatment for each patient," Mulder said.

Sean Young | EurekAlert!
Further information:
http://www.psu.edu

More articles from Studies and Analyses:

nachricht Researchers simplify tiny structures' construction drip by drip
12.11.2018 | Princeton University, Engineering School

nachricht Mandibular movement monitoring may help improve oral sleep apnea devices
06.11.2018 | Elsevier

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

Purdue cancer identity technology makes it easier to find a tumor's 'address'

16.11.2018 | Health and Medicine

Good preparation is half the digestion

16.11.2018 | Life Sciences

Microscope measures muscle weakness

16.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>